AAAAAA
Results:
1-24
|
Results: 24
Authors:
YOSHIMURA M
ASAI O
CHO WS
YASHIMA M
SUZUKI Y
KAKIHANA M
Citation: M. Yoshimura et al., LOW-TEMPERATURE SYNTHESIS OF CRYSTALLIZED CA1-XSRXTIO3 SOLID-SOLUTIONFILMS ON TITANIUM SUBSTRATES BY A MODIFIED HYDROTHERMAL-ELECTROCHEMICAL TECHNIQUE, Journal of alloys and compounds, 265(1-2), 1998, pp. 132-136
Authors:
USUI N
DOBASHI N
KOBAYASHI T
YANO S
MAKI N
ASAI O
SAITO T
YAMAGUCHI Y
WATANABE H
KATO A
OGIHARA A
KATORI M
NAGAMINE M
TAKEI Y
YAMAZAKI H
FUNAKOSHI S
TAJIMA N
OGAWA M
KURAISHI Y
Citation: N. Usui et al., ROLE OF DAUNORUBICIN IN THE INDUCTION THERAPY FOR ADULT ACUTE MYELOID-LEUKEMIA, Journal of clinical oncology, 16(6), 1998, pp. 2086-2092
Authors:
AKIYAMA M
UCHIYAMA H
HOSHI Y
YANO S
ASAI O
KURAISHI Y
YAMADA O
MIZOGUCHI H
YAMADA H
Citation: M. Akiyama et al., CHANGES OF TELOMERE LENGTH AFTER HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Experimental hematology, 26(8), 1998, pp. 359-359
Authors:
ASAI O
LONGO DL
TIAN ZG
HORNUNG RL
TAUB DD
RUSCETTI FW
MURPHY WJ
Citation: O. Asai et al., SUPPRESSION OF GRAFT-VERSUS-HOST DISEASE AND AMPLIFICATION OF GRAFT-VERSUS-TUMOR EFFECTS BY ACTIVATED NATURAL-KILLER-CELLS AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION, The Journal of clinical investigation, 101(9), 1998, pp. 1835-1842
Authors:
FUNAKOSHI S
TAUB DD
ASAI O
HIRANO A
RUSCETTI FW
LONGO DL
MURPHY WJ
Citation: S. Funakoshi et al., EFFECTS OF CD40 STIMULATION IN THE PREVENTION OF HUMAN EBV-LYMPHOMAGENESIS, Leukemia & lymphoma, 24(3-4), 1997, pp. 187
Authors:
HOSHI Y
MAKI N
ASAI O
Citation: Y. Hoshi et al., PREDEPOSIT AUTOLOGOUS BLOOD-TRANSFUSION IN INFANTS AND CHILDREN, Transfusion, 37(9), 1997, pp. 262-262
Authors:
TAUB DD
MURPHY WJ
ASAI O
FENTON RG
PELTZ G
KEY ML
TURCOVSKICORRALES S
LONGO DL
Citation: Dd. Taub et al., INDUCTION OF ALLOANTIGEN-SPECIFIC T-CELL TOLERANCE THROUGH THE TREATMENT OF HUMAN T-LYMPHOCYTES WITH WORTMANNIN, The Journal of immunology, 158(6), 1997, pp. 2745-2755
Authors:
FUNAKOSHI S
TAUB DD
ANVER MR
RAZIUDDIN A
ASAI O
REDDY V
RAGER H
FANSLOW WC
LONGO DL
MURPHY WJ
Citation: S. Funakoshi et al., IMMUNOLOGICAL AND HEMATOPOIETIC EFFECTS OF CD40 STIMULATION AFTER SYNGENEIC BONE-MARROW TRANSPLANTATION IN MICE, The Journal of clinical investigation, 99(3), 1997, pp. 484-491
Authors:
FUNAKOSHI S
HIRANO A
BECKWITH M
ASAI O
JORGENSEN G
TIAN ZG
HORNICK JL
HU PS
KHAWLI LA
EPSTEIN AL
LONGO DL
MURPHY WJ
Citation: S. Funakoshi et al., ANTITUMOR EFFECTS OF NONCONJUGATED MURINE LYM-2 AND HUMAN-MOUSE CHIMERIC CLL-1 MONOCLONAL-ANTIBODIES AGAINST VARIOUS HUMAN LYMPHOMA CELL-LINES IN-VITRO AND IN-VIVO, Blood, 90(8), 1997, pp. 3160-3166
Authors:
USUI N
DOBASHI N
KATO A
MAKI N
ASAI O
KOBAYASHI T
TAJIMA N
KURAISHI Y
Citation: N. Usui et al., PROGNOSTIC-SIGNIFICANCE OF AGE AND CYTOGENETICS IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 3798-3798
Authors:
KURAISHI Y
DOBASHI N
USUI N
YAMAZAKI H
ASAI O
KAITO H
FUJII T
OGASAWARA H
KISHI T
YAMAGUCHI K
TAJIMA N
KOBAYASHI T
Citation: Y. Kuraishi et al., ORAL ETOPOSIDE IN COMBINATION WITH DOXORUBICIN, VINCRISTINE AND PREDNISOLONE (AVEP) IN THE TREATMENT OF NON-HODGKINS-LYMPHOMAS, Blood, 90(10), 1997, pp. 855-855
Authors:
ASAI O
YANO S
KATO A
WATANABE H
KATORI M
NAGAMINE M
MAKI N
TAJIMA N
GOTO S
HIRABAYASHI N
KURAISHI Y
Citation: O. Asai et al., ADDING BUSULFAN WITH CYCLOPHOSPHAMIDE - TOTAL-BODY IRRADIATION AS PREPARATIVE REGIMEN FOR ALLOGENEIC TRANSPLANTATION REDUCED RELAPSE RATE IN MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 999-999
Authors:
DOBASHI N
USUI N
KOBAYASHI T
YAMAZAKI H
ASAI O
OGIHARA A
YANO S
KATO A
NAGAMINE M
SAITO T
YAMAGUCHI Y
TAJIMA N
TAKEI Y
KURAISHI Y
Citation: N. Dobashi et al., BEHENOYL CYTARABINE, ACLACINOMYCIN-A AND PREDNISOLONE (BAP) - AN EFFECTIVE REGIMEN FOR PREVIOUSLY TREATED PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA, Blood, 90(10), 1997, pp. 2266-2266
Authors:
MURPHY WJ
TIAN Z
ASAI O
HORNUNG R
LONGO DL
Citation: Wj. Murphy et al., ACTIVATED NATURAL-KILLER (NK) CELLS MEDIATE GRAFT-VERSUS-TUMOR (GVT) EFFECTS BUT INHIBIT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Journal of investigative medicine, 44(3), 1996, pp. 232-232
Authors:
ASAI O
FUNAKOSHI S
BECKWITH M
FANSLOW W
LONGO DL
MURPHY WJ
Citation: O. Asai et al., INHIBITION OF MURINE B-CELL LYMPHOMA GROWTH BY SOLUBLE RECOMBINANT MURINE CD40 LIGAND, The FASEB journal, 10(6), 1996, pp. 944-944
Authors:
MURPHY WJ
ASAI O
TIAN Z
HORNUNG R
LONGO DL
Citation: Wj. Murphy et al., ACTIVATED NATURAL-KILLER (NK) CELLS MEDIATE GRAFT-VERSUS-TUMOR (GVT) EFFECTS BUT INHIBIT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), The FASEB journal, 10(6), 1996, pp. 2509-2509
Authors:
MURPHY WJ
TIAN ZG
ASAI O
FUNAKOSHI S
ROTTER P
HENRY M
STRIETER RM
KUNKEL SL
LONGO DL
TAUB DD
Citation: Wj. Murphy et al., CHEMOKINES AND T-LYMPHOCYTE ACTIVATION .2. FACILITATION OF HUMAN T-CELL TRAFFICKING IN SEVERE COMBINED IMMUNODEFICIENCY MICE, The Journal of immunology, 156(6), 1996, pp. 2104-2111
Authors:
MURPHY WJ
ASAI O
HIRANO A
FUNAKOSHI S
FANSLOW WC
LONGO DL
Citation: Wj. Murphy et al., INHIBITION OF AGGRESSIVE HISTOLOGY HUMAN B-CELL LYMPHOMA GROWTH BY CD40 STIMULATION IN-VIVO - A COMPARISON OF A CD40 ANTIBODY AND A RECOMBINANT SOLUBLE CD40 LIGAND (SRCD40L), Blood, 88(10), 1996, pp. 343-343
Authors:
ASAI O
LONGO DL
RUSCETTI FW
MURPHY WJ
Citation: O. Asai et al., PREVENTION OF GRAFT-VERSUS-HOST DISEASE BY IL-2 ACTIVATED DONOR NK CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MICE, ROLE OF IL-2, Blood, 88(10), 1996, pp. 978-978
Authors:
HIRANO A
ASAI O
FUNAKOSHI S
LONGO D
MURPHY W
Citation: A. Hirano et al., EFFECTS OF CD40 STIMULATION ON HUMAN AND MURINE HEMATOPOIESIS, Blood, 88(10), 1996, pp. 1370-1370
Authors:
TIAN ZG
LONGO DL
FUNAKOSHI S
ASAI O
FERRIS DK
WIDMER M
MURPHY WJ
Citation: Zg. Tian et al., IN-VIVO ANTITUMOR EFFECTS OF UNCONJUGATED CD30 MONOCLONAL-ANTIBODIES ON HUMAN ANAPLASTIC LARGE-CELL LYMPHOMA XENOGRAFTS, Cancer research, 55(22), 1995, pp. 5335-5341
Authors:
FUNAKOSHI S
LONGO DL
ASAI O
BECKWITH M
KLINKE R
FANSLOW WC
MURPHY WJ
Citation: S. Funakoshi et al., INHIBITION OF AGGRESSIVE HISTOLOGY HUMAN B-CELL LYMPHOMA GROWTH BY SOLUBLE RECOMBINANT HUMAN CD40 LIGAND, Blood, 86(10), 1995, pp. 2397-2397
Authors:
DOBASHI N
USUI N
YAMAZAKI H
NAKAMURA T
KOBAYASHI T
ASAI O
KURAISHI Y
Citation: N. Dobashi et al., A PILOT-STUDY OF COMBINATION CHEMOTHERAPY WITH N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE, ACLACINOMYCIN-A AND PREDNISOLONE (BAP THERAPY) FOR REFRACTORY ADULT ACUTE MYELOGENOUS LEUKEMIA, Blood, 86(10), 1995, pp. 3010-3010
Authors:
USUI N
DOBASHI N
KOBAYASHI T
NAKAMURA T
YAMAZAKI H
KAITO H
ASAI O
FUNAKOSHI S
KURAISHI Y
Citation: N. Usui et al., ABCVEP-I-AND ABCVEP-II COMBINATION CHEMOTHERAPY WITH G-CSF IN PATIENTS WITH AGGRESSIVE LYMPHOMA, Blood, 84(10), 1994, pp. 10000650-10000650
Risultati:
1-24
|